STMN2 disrupts the microtubule–SMAD complex, promotes the release of SMAD2/3 from the microtubule network and phosphorylates it, promoting epithelial mesenchymal transformation in HCC [64]. The gene discussed is SMAD2; the disease is hepatocellular carcinoma.